Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
$4.18−0.23 (-5.22%)
Close on Nov 17, 2026Market cap $103.61MP/E –Yield –
Lexaria Bioscience total assets
Total assets on the balance sheet at the end of each period.
Lexaria Bioscience's total assets was $4.78M at May 31, 2026. For fiscal 2025 it was $4.18M, down 52.9% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $13.27M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $4.18M | -52.9% |
| FY2024 | Aug 31, 2024 | $8.87M | +187.5% |
| FY2023 | Aug 31, 2023 | $3.08M | -60.6% |
| FY2022 | Aug 31, 2022 | $7.83M | -41.0% |
| FY2021 | Aug 31, 2021 | $13.27M | +369.1% |
| FY2020 | Aug 31, 2020 | $2.83M | +5.7% |
| FY2019 | Aug 31, 2019 | $2.68M | +10.0% |
| FY2018 | Aug 31, 2018 | $2.43M | -15.0% |
| FY2017 | Aug 31, 2017 | $2.86M | +404.8% |
| FY2016 | Aug 31, 2016 | $566.64K | -20.4% |
| FY2015 | Aug 31, 2015 | $711.72K | -80.1% |
| FY2013 | Oct 31, 2013 | $3.57M | -14.8% |
| FY2012 | Oct 31, 2012 | $4.19M | -3.4% |
| FY2011 | Oct 31, 2011 | $4.34M | +32.4% |
| FY2010 | Oct 31, 2010 | $3.28M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | May 31, 2026 | $4.78M | -29.1% |
| Q2 FY2026CQ1 2026 | Feb 28, 2026 | $6.49M | -25.2% |
| Q1 FY2026CQ4 2025 | Nov 30, 2025 | $6.05M | -38.2% |
| Q4 FY2025CQ3 2025 | Aug 31, 2025 | $4.18M | -52.9% |
| Q3 FY2025CQ2 2025 | May 31, 2025 | $6.74M | -32.7% |
| Q2 FY2025CQ1 2025 | Feb 28, 2025 | $8.68M | +36.6% |
| Q1 FY2025CQ4 2024 | Nov 30, 2024 | $9.79M | +170.0% |
| Q4 FY2024CQ3 2024 | Aug 31, 2024 | $8.87M | +187.5% |
| Q3 FY2024CQ2 2024 | May 31, 2024 | $10.02M | +91.2% |
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | $6.35M | +30.8% |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | $3.63M | -41.6% |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | $3.08M | -60.6% |
| Q3 FY2023CQ2 2023 | May 31, 2023 | $5.24M | -42.7% |
| Q2 FY2023CQ1 2023 | Feb 28, 2023 | $4.85M | -57.5% |
| Q1 FY2023CQ4 2022 | Nov 30, 2022 | $6.21M | -47.1% |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | $7.83M | -41.0% |
| Q3 FY2022CQ2 2022 | May 31, 2022 | $9.14M | -13.4% |
| Q2 FY2022CQ1 2022 | Feb 28, 2022 | $11.41M | -6.2% |
| Q1 FY2022CQ4 2021 | Nov 30, 2021 | $11.75M | +440.2% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $13.27M | +369.1% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $10.55M | +217.7% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $12.17M | +512.8% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $2.17M | -20.8% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | $2.83M | +5.7% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $3.32M | -4.0% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | $1.99M | -53.5% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | $2.75M | -22.5% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $2.68M | +10.0% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | $3.46M | +27.6% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | $4.27M | +50.4% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | $3.54M | +41.9% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | $2.43M | -15.0% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | $2.71M | -13.8% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $2.84M | +226.9% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $2.50M | +119.7% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $2.86M | +404.8% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $3.14M | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $869.12K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $1.14M | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $566.64K | – |
See a number that looks wrong?